IMMUNOLOGY STUDIES
BioMedha’s immunology studies help to evaluate the immunomodulatory effects of test compounds to expedite the translation of your drug candidates into the clinic.
In vitro primary cell assessment plays a critical role in the progression of early-stage drug discovery and development.
BioMedha has access to fresh whole blood from healthy donors, which we use to isolate immune cells for the development of pre-clinical assays for compound testing. The team at BioMedha offers standard assays and custom assay support to help clients identify a specific immune cell subset or function relevant to their project. Our standardised assays, developed by in-house experts, are optimised to meet client project needs.
Immunology assay services include:
- Whole blood assays
- Immune cell assays
- Cytokine release
- Signalling pathway assays
- Functional assays
- Cytokine multiplexing
- Inflammation assays
- PBMC assays
- T cell assays (activation, inhibition, cytotoxicity, proliferation)
- B cell activation
- Neutrophils assays
- Chemotaxis
- NETosis assay
- Microglia functional assays
- Macrophage differentiation and functional assays
- Macrophage suppression assay
- Dendritic cell differentiation and functional assays
- Eosinophil activation assay
- CD45 toxicity
- Phagocytosis
- Migration assay
- Cell adhesion assay
- Immune cell death
- Biomarker assays
- T cell killing assay
- Co-culture assay
- Immune checkpoint bioassays
- PD-1 inhibition assays
- ADCC assays
- Degranulation assay
- Histamine release assay
- AChE inhibition assay